"Founded in 1866 as the Hebrew Hospital and Asylum, Sinai Hospital of Baltimore is a Jewish-sponsored health care organization providing care for all people. It is a nonprofit institution with a mission of providing quality patient care, teaching and research. Sinai is an agency of THE ASSOCIATED: Jewish Community Federation of Baltimore. Sinai Hospital of Baltimore provides a broad array of high quality, cost-effective health and health-related services to the people of greater Baltimore."

During the past decade, Sinai Center for Thrombosis Research conducted 5 clinical trials. In the 10-year time frame, 5 clinical trials started and 4 clinical trials were completed, i.e. on average, 80% percent of trials that started reached the finish line to date. In the past 5 years, 2 clinical trials started and 1 clinical trials were completed. i.e. 50% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Sinai Center for Thrombosis Research" #1 sponsor was "LifeBridge Health" with 8 trials, followed by "Brigham and Women's Hospital" with 1 trials sponsored, "Daiichi Sankyo, Inc." with 1 trials sponsored, "Haemonetics Corporation" with 1 trials sponsored and "Medstar Health Research Institute" with 1 trials sponsored. Other sponsors include -3 different institutions and companies that sponsored additional 7 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Sinai Center for Thrombosis Research" #1 collaborator was "Haemonetics Corporation" with 2 trials as a collaborator, "National Heart, Lung, and Blood Institute (NHLBI)" with 2 trials as a collaborator, "Accriva Diagnostics" with 1 trials as a collaborator, "Accumetrics, Inc." with 1 trials as a collaborator and "AstraZeneca" with 1 trials as a collaborator. Other collaborators include 2 different institutions and companies that were collaborators in the rest 12 trials.

According to Clinical.Site data, the most researched conditions in "Sinai Center for Thrombosis Research" are "Coronary Artery Disease" (5 trials), "Acute Coronary Syndrome" (2 trials), "Cardiovascular Disease" (2 trials), "Aortic Surgery or Redo Surgery" (1 trials) and "COVID-19" (1 trials). Many other conditions were trialed in "Sinai Center for Thrombosis Research" in a lesser frequency.

Most popular intervention types in "Sinai Center for Thrombosis Research" are "Drug" (9 trials), "Device" (2 trials), "Diagnostic Test" (1 trials) and "Procedure" (1 trials). Other intervention types were less common.

The name of intervention was led by "Prasugrel" (2 trials), "Arixtra" (1 trials), "Aspirin" (1 trials), "EC aspirin (Bayer®) ,EC omeprazole (Prilosec®) , Clopidogrel (Plavix®)" (1 trials) and "Edoxaban" (1 trials). Other intervention names were less common.

The vast majority of trials in "Sinai Center for Thrombosis Research" are 14 trials for "All" genders.

Currently, there are NaN active trials in "Sinai Center for Thrombosis Research". undefined are not yet recruiting, 1 are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 5 completed trials in Sinai Center for Thrombosis Research, undefined suspended trials, and 3 terminated clinical trials to date.

Out of the total trials that were conducted in Sinai Center for Thrombosis Research, 1 "Phase 1" clinical trials were conducted, 0 "Phase 2" clinical trials and 1 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 6 trials, and there were also 1 trials that are defined as “Not Applicable".